Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review.
Breast Cancer (Dove Med Press)
; 13: 151-159, 2021.
Article
in En
| MEDLINE
| ID: mdl-33658846
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Cancer (Dove Med Press)
Year:
2021
Document type:
Article
Affiliation country:
Ireland
Country of publication:
New Zealand